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Background. Early-warning scores (EWS) have the potential to improve resource allocation and hasten care in sub-Saharan Africa (SSA). Despite the high prevalence of HIV infection in SSA, current EWS do not take into account HIV serostatus.
Methods. We conducted a retrospective study at Mbarara Regional Referral Hospital (MRRH) in Uganda to evaluate the performance of CRB-65, modified early-warning score (MEWS), quick sepsis-related organ failure assessment (qSOFA), rapid acute physiology score (RAPS), rapid emergency medicine score (REMS), South African triage scale (SATS), and shock index (SI) in predicting mortality among HIVinfected patients presenting with sepsis. We included patients admitted with sepsis to MRRH between January 2014 and December 2015 that had an HIV-positive serostatus and at least one valid heart rate, respiratory rate, systolic blood pressure, diastolic blood pressure, temperature, and oxygen saturation. Glasgow coma scale was imputed with the median. We used the area under the receiver operating curve (AUC) with tenfold cross-validation to assess the performance of each EWS.
Results. Methods. The study participants were from the Multicenter AIDS Cohort Study (MACS) and the Women's Interagency HIV study (WIHS). A total of 248 men and 127 women participated. Pure-tone air conduction thresholds were collected for each ear at frequencies from 250 through 8000 Hz. Pure-tone averages (PTAs) for each ear were calculated as the mean of air conduction thresholds in low frequencies (i.e., 250, 500, 1,000, and 2,000 Hz) and high frequencies (i.e., 3,000, 4,000, 6,000, and 8,000 Hz). QOL (QOL) data were gathered with the Short Form 36 Health Survey and MOS-HIV instrument in the MACS and WIHS, respectively. A median regression analysis was performed to test the association of PTAs with QOL by HIV status.
Results. There was no significant association between hearing loss and QOL scores at low and high pure-tone averages in HIV-positive and negative individuals. HIV status, HIV biomarkers and treatment did not change the lack of association of low and high pure-tone averages with poorer QOL.
Conclusion. Although we did not find a statistically significant association of hearing loss with QOL by HIV status, testing for hearing loss with aging and recommending treatment may offset any presumed later life decline in QOL.
Disclosures. All authors: No reported disclosures. Background. Since the initial description of HIV/AIDS in the USA, cutaneous manifestations have been important in the diagnosis of the disease, and have been frequently associated with immune dysfunction. We sought to describe current dermatologic manifestations in our HIV seropositive veterans who are greater than 50 years of age and compare these to recent reports in HIV seronegative individuals.
Cutaneous Diseases among an
Methods. This was a retrospective cohort study performed at the South Texas Veterans Health Care System Immunosuppression Clinic. The aim was to review the charts of older HIV-positive veterans with a minimum age of 50, evaluated from January 1, 2015 to December 31, 2015, to investigate any manifestations of cutaneous pathology, HIV and non-HIV-related, analyze the correlation of the dermatological diagnoses made by the ID physicians and those made by dermatologists, and stratify the findings by age and CD4 counts.
Results. Two hundred and Forty-one of the 381 HIV seropositive clinic patients met the criteria (236 males, 5 females), the mean age was 59.95 ± 7.41. The median CD4 count was 446 cell/mm 3 . There were 558 dermatological diagnoses made in the year of 2015, 172 of these were new diagnoses. Of the 38 patients also seen by dermatologists for the presenting skin condition, 57.9% of the diagnoses agreed with the diagnosis from the referring infectious disease provider. 
